Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-75 |
Sentence |
denotes |
Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. |
T2 |
76-167 |
Sentence |
denotes |
The transcription factor NF-kappaB plays important roles in inflammation and cell survival. |
T3 |
168-342 |
Sentence |
denotes |
NF-kappaB is composed of homodimeric and heterodimeric complexes of Rel/NF-kappaB family members, including p65 (RelA), c-Rel (Rel), RelB, NF-kappaB1/p50, and NF-kappaB2/p52. |
T4 |
343-464 |
Sentence |
denotes |
Here we report the identification and characterization of a novel ZU5 and death domain-containing protein designated ZUD. |
T5 |
465-658 |
Sentence |
denotes |
In reporter gene assays, overexpression of ZUD inhibited NF-kappaB-dependent transcription induced by both tumor necrosis factor (TNF) and interleukin-1 and their downstream signaling proteins. |
T6 |
659-771 |
Sentence |
denotes |
Gel shift assays indicated that the overexpression of ZUD inhibited binding of NF-kappaB to its target sequence. |
T7 |
772-920 |
Sentence |
denotes |
ZUD is a cytoplasmic protein, and coimmunoprecipitation assays indicated that ZUD interacted with the NF-kappaB subunit p105 and transactivator p65. |
T8 |
921-1101 |
Sentence |
denotes |
Consistent with its role in inhibition of NF-kappaB-dependent transcription, ZUD sensitized cells to apoptosis induced by TNF and the TNF-related apoptosis-inducing ligand (TRAIL). |
T9 |
1102-1279 |
Sentence |
denotes |
Our findings suggest that ZUD is an inhibitor of NF-kappaB activation and that this protein may provide an alternative regulatory mechanism for NF-kappaB-mediated transcription. |
T1 |
0-75 |
Sentence |
denotes |
Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB. |
T2 |
76-167 |
Sentence |
denotes |
The transcription factor NF-kappaB plays important roles in inflammation and cell survival. |
T3 |
168-342 |
Sentence |
denotes |
NF-kappaB is composed of homodimeric and heterodimeric complexes of Rel/NF-kappaB family members, including p65 (RelA), c-Rel (Rel), RelB, NF-kappaB1/p50, and NF-kappaB2/p52. |
T4 |
343-464 |
Sentence |
denotes |
Here we report the identification and characterization of a novel ZU5 and death domain-containing protein designated ZUD. |
T5 |
465-658 |
Sentence |
denotes |
In reporter gene assays, overexpression of ZUD inhibited NF-kappaB-dependent transcription induced by both tumor necrosis factor (TNF) and interleukin-1 and their downstream signaling proteins. |
T6 |
659-771 |
Sentence |
denotes |
Gel shift assays indicated that the overexpression of ZUD inhibited binding of NF-kappaB to its target sequence. |
T7 |
772-920 |
Sentence |
denotes |
ZUD is a cytoplasmic protein, and coimmunoprecipitation assays indicated that ZUD interacted with the NF-kappaB subunit p105 and transactivator p65. |
T8 |
921-1101 |
Sentence |
denotes |
Consistent with its role in inhibition of NF-kappaB-dependent transcription, ZUD sensitized cells to apoptosis induced by TNF and the TNF-related apoptosis-inducing ligand (TRAIL). |
T9 |
1102-1279 |
Sentence |
denotes |
Our findings suggest that ZUD is an inhibitor of NF-kappaB activation and that this protein may provide an alternative regulatory mechanism for NF-kappaB-mediated transcription. |